Strategic Initiative

Slingshot members are tracking this corporate initiative:

TRACON (TCON) and Janssen (JNJ) Announce Strategic Licensing Collaboration for TRC253 in Treatment of Prostate Cancer and TRC694 in Treatment of Hematologic Malignancies

Source Link:: http://ir.traconpharma.com/phoenix.zhtml?c=253885&p=irol-newsArticle&ID=2206472

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies

Importance

High

Medium

Low

Impact on Stocks

TCON

100%

JNJ

100%

SIGN ME UP
I want to vote! LOG ME IN
Now!

Additional Information

Additional Relevant Details Janssen also made a $5 MM equity investment in TRACON through the purchase of common stock at $5.95 per share.

http://ir.traconphar...

Slingshot Insights Explained

JOIN FOR FREE TODAY

Strategic Initiative Date

Announcement Date:

Sep 28, 2016

Projected Implementation:

Q4, 2016

Relevance Tracked Until:

Q4, 2018

Related Projects

Don’t see a project related to the strategic initiative you care about?

Related Keywords Equity Investment, Strategic Collaboration, Trc253, Trc694, Prostate Cancer, Hematologic Malignancies, Myeloma